Takeda Pharmaceutical Co Ltd president Giles Richard Platford sells $1.16M of stock; filing shows no 10b5-1 plan

Giles Richard Platford sold about $1.2 million of Takeda Pharmaceutical Co Ltd (TAK) stock on Nov 4, according to an SEC filing. The president received an average of $20.90 for 55,617 shares.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The sale reduces the insider's holding by 17%, to 270,253 shares.

The trade was reported within two business days, as Section 16 requires.

The numbers below are taken from the Form 4 as filed with the SEC.

The sale

Company	Takeda Pharmaceutical Co Ltd (TAK)
Insider	Giles Richard Platford
Role	President
Transaction	Open-market sale (code S)
Shares	55,617
Average price	$20.90
Value	$1,162,395
Trade date	Nov 4, 2026
Filed with the SEC	Nov 5, 2026, 3:54 PM ET
Shares held after	270,253
Ownership	Direct
Rule 10b5-1 plan	Not marked in the filing

See this filing row by row in Insider Stock Trader

View the Form 4 on SEC.gov

Browse the latest insider selling · Browse the insider trading newsroom

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.